Şükrü Tüzmen

982 total citations
30 papers, 622 citations indexed

About

Şükrü Tüzmen is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Şükrü Tüzmen has authored 30 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Genetics and 8 papers in Hematology. Recurrent topics in Şükrü Tüzmen's work include Hemoglobinopathies and Related Disorders (10 papers), Iron Metabolism and Disorders (7 papers) and RNA Interference and Gene Delivery (4 papers). Şükrü Tüzmen is often cited by papers focused on Hemoglobinopathies and Related Disorders (10 papers), Iron Metabolism and Disorders (7 papers) and RNA Interference and Gene Delivery (4 papers). Şükrü Tüzmen collaborates with scholars based in United States, Cyprus and Türkiye. Şükrü Tüzmen's co-authors include Spyro Mousses, Hilmi Özçelik, Olli Kallioniemi, Alan N. Schechter, David O. Azorsa, Ghazi Omar Tadmouri, Gargi D. Basu, Sevtap Savas, Shahid Mahmood Baig and Jeffrey Kiefer and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Şükrü Tüzmen

30 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Şükrü Tüzmen United States 14 385 144 127 121 96 30 622
Isha Kapoor India 13 376 1.0× 107 0.7× 84 0.7× 81 0.7× 141 1.5× 25 569
Alberto Risueño United States 12 437 1.1× 91 0.6× 192 1.5× 262 2.2× 87 0.9× 25 678
Mercè de Frías Spain 13 511 1.3× 184 1.3× 75 0.6× 82 0.7× 237 2.5× 17 734
Iris Z. Uras Austria 14 481 1.2× 136 0.9× 152 1.2× 123 1.0× 240 2.5× 15 751
Magali Herrant France 10 637 1.7× 106 0.7× 180 1.4× 95 0.8× 200 2.1× 11 883
Maria Alessandra Santucci Italy 17 432 1.1× 112 0.8× 296 2.3× 51 0.4× 136 1.4× 49 740
Andrea Ghelli Luserna di Rorà Italy 13 513 1.3× 63 0.4× 115 0.9× 98 0.8× 303 3.2× 38 735
Tara M. Love United States 8 547 1.4× 173 1.2× 88 0.7× 184 1.5× 167 1.7× 10 741
Kyoichiro Higashi Japan 11 399 1.0× 112 0.8× 47 0.4× 63 0.5× 110 1.1× 15 628
Krysta Schlis United States 4 405 1.1× 68 0.5× 101 0.8× 67 0.6× 182 1.9× 6 625

Countries citing papers authored by Şükrü Tüzmen

Since Specialization
Citations

This map shows the geographic impact of Şükrü Tüzmen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Şükrü Tüzmen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Şükrü Tüzmen more than expected).

Fields of papers citing papers by Şükrü Tüzmen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Şükrü Tüzmen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Şükrü Tüzmen. The network helps show where Şükrü Tüzmen may publish in the future.

Co-authorship network of co-authors of Şükrü Tüzmen

This figure shows the co-authorship network connecting the top 25 collaborators of Şükrü Tüzmen. A scholar is included among the top collaborators of Şükrü Tüzmen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Şükrü Tüzmen. Şükrü Tüzmen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagy, Benedek, et al.. (2021). Reaction Systems for Modeling and Validation of Biological Signaling Pathways: G1/S Checkpoint of the Cell Cycle. Acta Polytechnica Hungarica. 18(6). 7–23. 6 indexed citations
2.
Tüzmen, Şükrü, et al.. (2020). MicroRNAs and microbiota: Is there a cross talk?. Drugs of today. 56(3). 211–211. 4 indexed citations
3.
Nagy, Benedek, et al.. (2019). Potential Therapeutic Modalities of Reawakening Fetal Hemoglobin Simulated by Reaction Systems. Acta Polytechnica Hungarica. 16(3). 1 indexed citations
4.
Tüzmen, Şükrü, et al.. (2019). Patisiran for the treatment of patients with familial amyloidpolyneuropathy. Drugs of today. 55(5). 315–315. 10 indexed citations
5.
Tüzmen, Şükrü, et al.. (2017). Update on the clinical utility of an RNA interference-based treatment: focus on Patisiran. Pharmacogenomics and Personalized Medicine. Volume 10. 267–278. 54 indexed citations
6.
Tüzmen, Şükrü, et al.. (2017). ATTRACTIVE APPROACHES in DRUG DELIVERY: BIO-BASED CARRIERS for siRNA TARGETING. SHILAP Revista de lepidopterología. 1–1. 2 indexed citations
7.
Yılmaz, Elvan, et al.. (2013). Blood contact properties of ascorbyl chitosan. Journal of Biomaterials Science Polymer Edition. 24(17). 1969–1987. 3 indexed citations
8.
Savas, Sevtap, David O. Azorsa, Hamdi Jarjanazi, et al.. (2011). NCI60 Cancer Cell Line Panel Data and RNAi Analysis Help Identify EAF2 as a Modulator of Simvastatin and Lovastatin Response in HCT-116 Cells. PLoS ONE. 6(4). e18306–e18306. 14 indexed citations
9.
Gökmen‐Polar, Yesim, Rutika Mehta, Şükrü Tüzmen, et al.. (2010). Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypes. Breast Cancer Research and Treatment. 124(2). 327–335. 15 indexed citations
10.
Tüzmen, Şükrü, et al.. (2010). RNAi-Based Functional Pharmacogenomics. Methods in molecular biology. 700. 271–290. 3 indexed citations
11.
Carrigan, Patricia E., Petek Ballar, & Şükrü Tüzmen. (2010). Site-Directed Mutagenesis. Methods in molecular biology. 700. 107–124. 25 indexed citations
12.
Başak, A. Nazlı & Şükrü Tüzmen. (2010). Genetic Predisposition to β-Thalassemia and Sickle Cell Anemia in Turkey: A Molecular Diagnostic Approach. Methods in molecular biology. 700. 291–307. 3 indexed citations
13.
Basu, Gargi D., David O. Azorsa, Jeffrey Kiefer, et al.. (2008). Functional evidence implicating S100P in prostate cancer progression. International Journal of Cancer. 123(2). 330–339. 62 indexed citations
14.
Jarjanazi, Hamdi, Jeffrey Kiefer, Sevtap Savas, et al.. (2008). Discovery of genetic profiles impacting response to chemotherapy: application to gemcitabine. Human Mutation. 29(4). 461–467. 17 indexed citations
15.
Savinainen, Kimmo, David O. Azorsa, Gargi D. Basu, et al.. (2007). Intersex-like ( IXL ) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification. Cancer Research. 67(5). 1943–1949. 61 indexed citations
16.
Tüzmen, Şükrü, Jeffrey Kiefer, & Spyro Mousses. (2007). Validation of Short Interfering RNA Knockdowns by Quantitative Real-Time PCR. Humana Press eBooks. 353. 177–204. 12 indexed citations
17.
Tüzmen, Şükrü & Alan N. Schechter. (2001). Genetic diseases of hemoglobin: diagnostic methods for elucidating β -thalassemia mutations. Blood Reviews. 15(1). 19–29. 31 indexed citations
18.
Tadmouri, Ghazi Omar, et al.. (1998). Molecular and population genetic analyses of β-Thalassemia in Turkey. American Journal of Hematology. 57(3). 215–220. 70 indexed citations
19.
Tüzmen, Şükrü, et al.. (1998). Molecular and population genetic analyses of β‐Thalassemia in Turkey. American Journal of Hematology. 57(3). 215–220. 3 indexed citations
20.
Tadmouri, Ghazi Omar, et al.. (1997). Rare beta-thalassemia mutation in a Turkish patient: FSC-36/37 (-T).. PubMed. 69(2). 263–7. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isha Kapoor Breakdown of academic impact, for papers by Alberto Risueño Breakdown of academic impact, for papers by Mercè de Frías Breakdown of academic impact, for papers by Iris Z. Uras Breakdown of academic impact, for papers by Magali Herrant Breakdown of academic impact, for papers by Maria Alessandra Santucci Breakdown of academic impact, for papers by Andrea Ghelli Luserna di Rorà Breakdown of academic impact, for papers by Tara M. Love Breakdown of academic impact, for papers by Kyoichiro Higashi Breakdown of academic impact, for papers by Krysta Schlis
Rankless by CCL
2026